Change Healthcare announces blockchain solution for healthcare

Change Healthcare, one of the largest independent healthcare IT companies in the U.S., has announced the launch of a blockchain solution for healthcare.

Announced at the Distributed: Health 2017 conference, the Change Healthcare Intelligent Healthcare Network will support blockchain transactions by the end of th year. The enterprise-scaled solution hopes to improve revenue cycle efficiency, real-time analytics, reduce costs and develop new services.

“We are excited to work alongside our customers and partners to make blockchain real in healthcare,” said Change Healthcare CEO Neil de Crescenzo. “As today’s healthcare system becomes more value-based, it’s essential that we aggressively and pervasively introduce new technologies into healthcare at scale—whether they leverage blockchain, artificial intelligence, or other emerging capabilities with the potential to improve outcomes and efficiencies. We are initially introducing blockchain technology to create a distributed ledger that makes claims processing and secure payment transactions work more efficiently and cost effectively for all healthcare stakeholders.”

Change Healthcare is set to employ Hyperledger Fabric 1.0, an open source blockchain framework, as the foundation for blockchain application development. As a member of the Hyperledger Governing Board, Change Healthcare will contribute code to the open source community to improve blockchain applications for healthcare industries.

“Change Healthcare is uniquely positioned to lead blockchain innovation for healthcare, and we are excited to participate in this transformative undertaking with them,” said Brian Behlendorf, executive director of Hyperledger. “With its security, transparency of transactions, and ability for all stakeholders to access the same information, blockchain technology has potential to increase payment accuracy and revenue velocity, which will benefit payers, providers, and consumers themselves.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.